Since, there are no previous reports regarding any therapeutic effects of silencing mutant Htt in HD hearts, we performed a quantitative analysis of previously established biomarkers linked to the HD related cardiomyopathy in HD mouse models (Mielcarek et al., 2014a). The gene discussed is HTT; the disease is Huntington disease.